| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Revenue | 5.6 | 4.8 |
| Gross profit | 3.3 | 2.9 |
| Profit before tax | 0.5 | 0.3 |
| Net income | 0.5 | 0.3 |
| EPS (diluted, $ a share) | $0.05 | $0.03 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
| Net income, year on year | +51.9% |
|---|---|
| Revenue, year on year | +18.0% |
| Gross margin | 58.4% |
| Operating margin | 8.9% |
10-Q filed with the SEC, NASDAQ: NEPH. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
Nephros Inc: key numbers
- Share price
- $3.00Close, Nov 16
- Market cap
- $32.6M
- Shares outstanding
- 10.87MLatest SEC cover page
- Sector
- Industrial Applications and Services
- Industry
- Surgical & Medical Instruments & ApparatusSIC 3841
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from Nephros Inc
All →Nephros Financial Results
Nephros reported Q3 2026 net revenue of $5.6 million, an 18% increase year-over-year, and net income of $0.5 million. The company expanded its active installed base to a record 1,766 sites, adding 31 new customer sites during the quarter across healthcare and commercial markets.
- Term
- Q3 2026
“The third quarter of 2026 continued the strong momentum we have built across Nephros. Net revenue increased approximately 18% over the prior-year quarter to $5.6 million, following the record $6.0 million we reported in the second quarter. Importantly, we continued to translate that growth into improved profitability, generating net income of approximately $0.5 million and Adjusted EBITDA of approximately $0.6 million.”
Robert Banks, President and Chief Executive Officer
“One of the most encouraging indicators during the quarter was the continued expansion of our customer base. We added approximately 31 new customer sites in the third quarter, bringing our active installed base to a record 1,766 sites.”
Robert Banks, President and Chief Executive Officer
Nephros Shareholder Meeting
Nephros, Inc. has scheduled its 2026 Annual Meeting of Stockholders for November 25, 2026, to be held virtually. Because the meeting date has shifted by more than 30 days from the anniversary of the previous year's meeting, the company has established new deadlines of October 23, 2026, for stockholder proposals and director nominations.